Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice

Area of Science:

• Toxicology
• Bone Biology
• Molecular Biology

Background:

• Cadmium (Cd) is a toxic heavy metal known to induce bone loss.
• Metallothioneins (MTs) are involved in heavy metal detoxification.
• Understanding the molecular mechanisms of Cd-induced bone loss is crucial for developing interventions.

Purpose of the Study:

• To develop and characterize an in vivo mouse model for cadmium-induced bone loss.
• To investigate the role of metallothioneins in cadmium's effect on bone.
• To identify molecular pathways involved in cadmium-induced bone demineralization.

Main Methods:

• Established an in vivo mouse model using three strains: CF1, metallothionein-wild-type (MTN), and MT1,2-deficient (MT1,2KO).
• Administered cadmium or vehicle via gavage and monitored fecal calcium excretion.
• Utilized microarray analysis of bone RNA to assess gene expression changes.

Main Results:

• Cadmium exposure led to increased fecal calcium excretion, indicating bone mineral loss, with significant strain-dependent differences.
• Metallothionein 1 (MT1) and Metallothionein 2 (MT2) gene expression was upregulated by cadmium.
• p38 MAPK (MAPK 14) and specific osteoclast-related genes (vacuolar proton pump ATPase, integrin alpha v) were upregulated by cadmium.

Conclusions:

• The developed mouse model effectively demonstrates cadmium-induced bone loss.
• Cadmium stimulates bone demineralization, potentially through a p38 MAPK pathway.
• Osteoclast activation is implicated in the bone loss mechanism induced by cadmium.